Missionpharma, officially known as Missionpharma A/S, is a leading provider of healthcare solutions headquartered in Denmark (DK). Established in 2000, the company has made significant strides in the pharmaceutical and medical supply industry, focusing on the procurement and distribution of essential medicines and medical devices across various regions, including Africa and Asia. With a commitment to improving healthcare access, Missionpharma offers a diverse range of products, including generic pharmaceuticals, surgical instruments, and diagnostic tools. Their unique approach combines quality assurance with competitive pricing, ensuring that healthcare providers receive reliable products tailored to their needs. Recognised for their dedication to social responsibility, Missionpharma has positioned itself as a trusted partner in global health initiatives, contributing to improved health outcomes in underserved communities.
How does Missionpharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Missionpharma's score of 9 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Missionpharma reported total carbon emissions of approximately 273,000 kg CO2e, with emissions solely from Scope 1. There were no reported emissions from Scope 2 or Scope 3. In 2024, emissions increased to about 305,000 kg CO2e, again entirely from Scope 1, with no contributions from Scope 2 or Scope 3. Despite the increase in emissions, Missionpharma has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The company has not committed to any climate pledges or science-based targets for emissions reduction. As a global entity headquartered in Denmark (DK), Missionpharma's climate commitments and emissions data reflect the broader industry context, where many organisations are increasingly focusing on sustainability and carbon neutrality. However, the lack of defined reduction strategies may indicate an area for potential improvement in their environmental impact efforts.
Access structured emissions data, company-specific emission factors, and source documents
Add to project2023 | 2024 | |
---|---|---|
Scope 1 | 273,000 | 000,000 |
Scope 2 | - | - |
Scope 3 | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Missionpharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.